FDA Inspection 1242242 — NYU Robert Grossman School Of Medicine Radioactive Drug Research Committee

NYU Robert Grossman School Of Medicine Radioactive Drug Research Committee — FEI 3015434776

The FDA completed an inspection of NYU Robert Grossman School Of Medicine Radioactive Drug Research Committee on Jun 26, 2024 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Radioactive Drug Research Committee

Citations

IDCFRDescription
1795821 CFR 361.1(c)(2)Signatures of RDRC Chairman
1796121 CFR 361.1(c)(2)RDRC has not kept minutes of its meetings
1797821 CFR 361.1(d)(5)Obtaining informed consent
1799121 CFR 361.1(d)(9)Institutional Review Board (IRB) approved research